Bottom line
Is MNDFX a good fund? The bottom line
MNDFX is the Class I share class of Disciplined Value Series, a managed large value mutual fund from Manning & Napier.
It charges 0.57% — about $57 a year on every $10,000 invested, cheaper than 76% of large value funds we track.
It returned +15.9% over one year, +9.9% a year over five years, +10.8% a year over ten (as of Dec 31, 2025, per its prospectus).
With $131 million in net assets and 127 holdings, its largest position is Merck & Company Inc (3.8%) and the top 10 make up 25.6% of the portfolio.
What stands out
- Low cost: cheaper than 76% of large value peers
Updated Nov 19, 2026
What MNDFX invests in
To provide competitive returns consistent with the broad equity market while also providing a level of capital protection during market downturns.
The Series will, under normal circumstances, invest at least 80% of its assets in dividend-paying common stocks. The Series principally invests in the common stocks of mid- to large- capitalization companies. The Advisor constructs a portfolio consisting primarily of U.S. companies trading on U.S. stock exchanges that it believes will provide competitive returns consistent with the broad equity market while also providing a level of capital protection during sustained market downturns. In selecting securities for the Series, the Advisor uses a systematic process to identify stocks of companies that it believes are undervalued in the market, based on factors such as free cash flow generation and earnings power, and that meet other investment criteria relating to minimum dividend yield, dividend sustainability, and financial health. The Series investment strategy may involve allocating…
From the fund's prospectus (filed Mar 2, 2026).
MNDFX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| MNDFX | +15.9% | +9.9% | +10.8% |
| Large Value median | +13.6% | +11.3% | +10.2% |
Source: Fund prospectus, as of Dec 31, 2025
What MNDFX costs
On a $10,000 investment, MNDFX's 0.57% expense ratio costs about $57 a year. The prospectus estimates $713 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.
MNDFX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Merck & Company Inc MRK | 3.83% |
| 2 | Citigroup Inc C | 3.48% |
| 3 | Unitedhealth Group Inc UNH | 2.79% |
| 4 | Wells Fargo & Company WFC | 2.55% |
| 5 | Gilead Sciences Inc GILD | 2.50% |
| 6 | Conocophillips COP | 2.37% |
| 7 | Bristol-myers Squibb Company BMY | 2.25% |
| 8 | Exxonmobil Holdings Corp XOM | 2.01% |
| 9 | Qualcomm Inc QCOM | 1.97% |
| 10 | US Bancorp USB | 1.87% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 25.6% of the fund. See all top 25 holdings and asset mix →